Literature DB >> 6213724

Immunoresponsiveness in acute babesiosis in humans.

J L Benach, G S Habicht, M I Hamburger.   

Abstract

Immunoresponsiveness in patients with acute babesiosis was characterized. Lymphocyte subpopulations, mononuclear cell responses to nonspecific mitogens, and serum immunochemical values were studied in patients during acute babesiosis and after recovery (four to 40 months), controls, and seropositive individuals. Serum studies were also carried out retrospectively on stored sera from patients with babesiosis. Mean and differential lymphocyte counts and percentages of B lymphocytes were higher than in controls in patients with acute babesiosis, and levels of T lymphocytes bearing the IgG Fc receptor (T gamma) were significantly (P less than 0.01) elevated. Responses to nonspecific mitogens were suppressed during acute babesiosis. Levels of serum IgG and IgM and Clq binding were significantly increased whereas C3 and C4 levels and hemolytic activity were suppressed in acute-phase sera. The apparent paradox of an increased T suppressor/cytotoxic population in the presence of evidence of increased in vivo lymphocyte function is discussed in terms of the heterogeneity of the T gamma subpopulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6213724     DOI: 10.1093/infdis/146.3.369

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  Babesiosis in California.

Authors:  A F Jerant; A D Arline
Journal:  West J Med       Date:  1993-06

Review 2.  Babesiosis.

Authors:  M J Homer; I Aguilar-Delfin; S R Telford; P J Krause; D H Persing
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

3.  Reduced dietary protein content suppresses infection with Babesia microti.

Authors:  C L Tetzlaff; M A Carlomagno; D N McMurray
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

4.  Discovery of the Lyme Disease Agent.

Authors:  Alan G Barbour; Jorge L Benach
Journal:  mBio       Date:  2019-09-17       Impact factor: 7.867

Review 5.  Human babesiosis in Europe: what clinicians need to know.

Authors:  A Hildebrandt; J S Gray; K-P Hunfeld
Journal:  Infection       Date:  2013-10-09       Impact factor: 7.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.